Excaliard Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Excaliard Pharmaceuticals Ownership

Who owns Excaliard Pharmaceuticals?

Excaliard Pharmaceuticals is owned by Pfizer. It was acquired on November 22, 2011.

Was Excaliard Pharmaceuticals formerly PE-backed?

Yes. Excaliard Pharmaceuticals was formerly owned by 1 private investor.

Excaliard Pharmaceuticals Business Overview

Where is Excaliard Pharmaceuticals headquartered?

Excaliard Pharmaceuticals is headquartered in Carlsbad, California.

What sector is Excaliard Pharmaceuticals in?

Excaliard Pharmaceuticals is a life science company.

When was Excaliard Pharmaceuticals founded?

Excaliard Pharmaceuticals was founded in 2006.

Life Science M&A Summary in 2011

Out of 60 sectors in the Mergr database, life science ranked 11 in number of deals in 2011. The largest life science acquisition in 2011 was Genzyme - which was acquired by Sanofi SA for $20.1B.

Join Mergr to view all 172 acquisitions of life science companies in 2011, including 23 acquisitions by private equity firms, and 149 by strategics.

Excaliard Pharmaceuticals, Inc.

2141 Palomar Airport Road, Suite 300,
Carlsbad, California 92011
United States,
+760-431-1850
www.excaliard.com

Excaliard is a private biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and other fibrotic diseases.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.